Unknown

Dataset Information

0

Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy.


ABSTRACT: Chimeric antigen receptor (CAR) T cells have been highly successful in treating hematological malignancies, including acute and chronic lymphoblastic leukemia. However, treatment of solid tumors using CAR T cells has been largely unsuccessful to date, partly because of tumor-induced immunosuppressive mechanisms, including adenosine production. Previous studies have shown that adenosine generated by tumor cells potently inhibits endogenous antitumor T cell responses through activation of adenosine 2A receptors (A2ARs). Herein, we have observed that CAR activation resulted in increased A2AR expression and suppression of both murine and human CAR T cells. This was reversible using either A2AR antagonists or genetic targeting of A2AR using shRNA. In 2 syngeneic HER2+ self-antigen tumor models, we found that either genetic or pharmacological targeting of the A2AR profoundly increased CAR T cell efficacy, particularly when combined with PD-1 blockade. Mechanistically, this was associated with increased cytokine production of CD8+ CAR T cells and increased activation of both CD8+ and CD4+ CAR T cells. Given the known clinical relevance of the CD73/adenosine pathway in several solid tumor types, and the initiation of phase I trials for A2AR antagonists in oncology, this approach has high translational potential to enhance CAR T cell efficacy in several cancer types.

SUBMITTER: Beavis PA 

PROVIDER: S-EPMC5330718 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications


Chimeric antigen receptor (CAR) T cells have been highly successful in treating hematological malignancies, including acute and chronic lymphoblastic leukemia. However, treatment of solid tumors using CAR T cells has been largely unsuccessful to date, partly because of tumor-induced immunosuppressive mechanisms, including adenosine production. Previous studies have shown that adenosine generated by tumor cells potently inhibits endogenous antitumor T cell responses through activation of adenosin  ...[more]

Similar Datasets

| S-EPMC4778162 | biostudies-literature
| S-EPMC7388644 | biostudies-literature
| S-EPMC6756044 | biostudies-literature
| S-EPMC5589087 | biostudies-other
| S-EPMC3033501 | biostudies-literature
| S-EPMC8293573 | biostudies-literature
| S-EPMC7269829 | biostudies-literature
2021-06-03 | GSE151774 | GEO
| S-EPMC7994267 | biostudies-literature
| S-EPMC10537973 | biostudies-literature